[Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
Personal experience with human chorionic gonadotropin in the treatment of chronic obliterating peripheral atherosclerosis of the lower limbs in various stages in a series of 54 persenile and senile subjects is reported. Following protracted i.m. administration, the product normalised blood lipid values and brought about the regression of attenuation of subjective and objective symptoms that had been disclosed instrumentally in many cases. It is felt, therefore, that this drug can be used as a further weapon in the treatment of these arteriopathies.
D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D012881:Skin Temperature
D006063:Chorionic Gonadotropin; D008055:Lipids
La gonadotropina corionica umana nel trattamento delle arteriopatie obliteranti croniche periferiche aterosclerotiche degli arti inferiori.